vs

Side-by-side financial comparison of CVRx, Inc. (CVRX) and Taoping Inc. (TAOP). Click either name above to swap in a different company.

Taoping Inc. is the larger business by last-quarter revenue ($17.6M vs $16.0M, roughly 1.1× CVRx, Inc.). Taoping Inc. runs the higher net margin — -26.6% vs -74.5%, a 47.9% gap on every dollar of revenue. On growth, CVRx, Inc. posted the faster year-over-year revenue change (4.4% vs -2.6%). Taoping Inc. produced more free cash flow last quarter ($-2.8M vs $-9.8M).

CVRx, Inc. is a commercial-stage medical technology company specializing in neuromodulation therapies for chronic cardiovascular diseases. Its flagship Barostim system treats heart failure and resistant hypertension, with core markets across North America and Europe, serving patients unresponsive to conventional drug treatments.

Taoping Inc. is a China-based technology firm providing smart cloud services, digital media solutions, and targeted internet advertising services. Its core segments cover smart city support, enterprise digital transformation tools, and offline new retail digital operations, serving mainly enterprise and public sector clients in the domestic market.

CVRX vs TAOP — Head-to-Head

Bigger by revenue
TAOP
TAOP
1.1× larger
TAOP
$17.6M
$16.0M
CVRX
Growing faster (revenue YoY)
CVRX
CVRX
+7.1% gap
CVRX
4.4%
-2.6%
TAOP
Higher net margin
TAOP
TAOP
47.9% more per $
TAOP
-26.6%
-74.5%
CVRX
More free cash flow
TAOP
TAOP
$7.0M more FCF
TAOP
$-2.8M
$-9.8M
CVRX

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CVRX
CVRX
TAOP
TAOP
Revenue
$16.0M
$17.6M
Net Profit
$-11.9M
$-4.7M
Gross Margin
86.3%
10.1%
Operating Margin
-69.8%
-23.8%
Net Margin
-74.5%
-26.6%
Revenue YoY
4.4%
-2.6%
Net Profit YoY
-12.0%
-894.8%
EPS (diluted)
$-0.45
$-6.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVRX
CVRX
TAOP
TAOP
Q4 25
$16.0M
Q3 25
$14.7M
Q2 25
$13.6M
$17.6M
Q1 25
$12.3M
Q4 24
$15.3M
$18.6M
Q3 24
$13.4M
Q2 24
$11.8M
$18.1M
Q1 24
$10.8M
Net Profit
CVRX
CVRX
TAOP
TAOP
Q4 25
$-11.9M
Q3 25
$-12.9M
Q2 25
$-14.7M
$-4.7M
Q1 25
$-13.8M
Q4 24
$-10.7M
$-2.4M
Q3 24
$-13.1M
Q2 24
$-14.0M
$588.7K
Q1 24
$-22.2M
Gross Margin
CVRX
CVRX
TAOP
TAOP
Q4 25
86.3%
Q3 25
86.8%
Q2 25
84.3%
10.1%
Q1 25
83.5%
Q4 24
83.2%
19.5%
Q3 24
83.2%
Q2 24
83.9%
22.9%
Q1 24
85.0%
Operating Margin
CVRX
CVRX
TAOP
TAOP
Q4 25
-69.8%
Q3 25
-83.5%
Q2 25
-105.8%
-23.8%
Q1 25
-108.8%
Q4 24
-67.0%
-8.0%
Q3 24
-97.3%
Q2 24
-118.3%
-0.7%
Q1 24
-206.4%
Net Margin
CVRX
CVRX
TAOP
TAOP
Q4 25
-74.5%
Q3 25
-87.6%
Q2 25
-108.4%
-26.6%
Q1 25
-111.5%
Q4 24
-69.4%
-13.0%
Q3 24
-98.0%
Q2 24
-118.8%
3.3%
Q1 24
-206.0%
EPS (diluted)
CVRX
CVRX
TAOP
TAOP
Q4 25
$-0.45
Q3 25
$-0.49
Q2 25
$-0.57
$-6.54
Q1 25
$-0.53
Q4 24
$-0.39
$-3.58
Q3 24
$-0.57
Q2 24
$-0.65
$3.29
Q1 24
$-1.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVRX
CVRX
TAOP
TAOP
Cash + ST InvestmentsLiquidity on hand
$75.7M
$2.2M
Total DebtLower is stronger
$5.8M
Stockholders' EquityBook value
$39.3M
$14.5M
Total Assets
$104.8M
$30.3M
Debt / EquityLower = less leverage
0.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVRX
CVRX
TAOP
TAOP
Q4 25
$75.7M
Q3 25
$85.1M
Q2 25
$95.0M
$2.2M
Q1 25
$102.7M
Q4 24
$105.9M
$1.6M
Q3 24
$100.2M
Q2 24
$70.4M
$480.3K
Q1 24
$80.1M
Total Debt
CVRX
CVRX
TAOP
TAOP
Q4 25
Q3 25
Q2 25
$5.8M
Q1 25
Q4 24
$5.8M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CVRX
CVRX
TAOP
TAOP
Q4 25
$39.3M
Q3 25
$48.1M
Q2 25
$57.9M
$14.5M
Q1 25
$71.1M
Q4 24
$71.1M
$15.9M
Q3 24
$65.2M
Q2 24
$55.2M
$15.8M
Q1 24
$66.3M
Total Assets
CVRX
CVRX
TAOP
TAOP
Q4 25
$104.8M
Q3 25
$111.3M
Q2 25
$119.6M
$30.3M
Q1 25
$129.6M
Q4 24
$133.4M
$35.1M
Q3 24
$127.7M
Q2 24
$96.0M
$34.1M
Q1 24
$106.2M
Debt / Equity
CVRX
CVRX
TAOP
TAOP
Q4 25
Q3 25
Q2 25
0.40×
Q1 25
Q4 24
0.37×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVRX
CVRX
TAOP
TAOP
Operating Cash FlowLast quarter
$-9.8M
$-1.5M
Free Cash FlowOCF − Capex
$-9.8M
$-2.8M
FCF MarginFCF / Revenue
-61.3%
-16.0%
Capex IntensityCapex / Revenue
0.4%
7.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-40.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVRX
CVRX
TAOP
TAOP
Q4 25
$-9.8M
Q3 25
$-9.7M
Q2 25
$-7.9M
$-1.5M
Q1 25
$-12.8M
Q4 24
$-8.0M
$147.4K
Q3 24
$-10.4M
Q2 24
$-9.8M
$-2.5M
Q1 24
$-10.9M
Free Cash Flow
CVRX
CVRX
TAOP
TAOP
Q4 25
$-9.8M
Q3 25
$-10.0M
Q2 25
$-8.0M
$-2.8M
Q1 25
$-12.9M
Q4 24
$-8.1M
$-129.3K
Q3 24
$-10.4M
Q2 24
$-10.2M
$-3.3M
Q1 24
$-11.8M
FCF Margin
CVRX
CVRX
TAOP
TAOP
Q4 25
-61.3%
Q3 25
-68.1%
Q2 25
-59.2%
-16.0%
Q1 25
-104.3%
Q4 24
-52.5%
-0.7%
Q3 24
-78.1%
Q2 24
-86.3%
-18.3%
Q1 24
-109.7%
Capex Intensity
CVRX
CVRX
TAOP
TAOP
Q4 25
0.4%
Q3 25
2.0%
Q2 25
0.8%
7.6%
Q1 25
0.9%
Q4 24
0.3%
1.5%
Q3 24
0.3%
Q2 24
3.0%
4.3%
Q1 24
8.5%
Cash Conversion
CVRX
CVRX
TAOP
TAOP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-4.30×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CVRX
CVRX

US$14.9M93%
Other$1.1M7%

TAOP
TAOP

Segment breakdown not available.

Related Comparisons